Suppr超能文献

严重皮肤不良反应的遗传学

Genetics of Severe Cutaneous Adverse Reactions.

作者信息

Yang Shang-Chen, Chen Chun-Bing, Lin Mao-Ying, Zhang Zhi-Yang, Jia Xiao-Yan, Huang Ming, Zou Ya-Fen, Chung Wen-Hung

机构信息

Department of Dermatology, Xiamen Chang Gung Allergology Consortium, Xiamen Chang Gung Hospital, Xiamen, China.

Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

出版信息

Front Med (Lausanne). 2021 Jul 15;8:652091. doi: 10.3389/fmed.2021.652091. eCollection 2021.

Abstract

Severe cutaneous adverse reactions (SCARs) including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and drug rash with eosinophilia and systemic symptoms (DRESS) are T cells-mediated life-threatening immune reactions, most commonly induced by drug. The last decade has seen significant progress in SCARs research. Recent studies have unveiled the pathogenesis of SCARs involved in susceptible genes, including human leukocyte antigens (HLA) and drugs-T cell receptor (TCR) interaction that may trigger T cell activation with downstream immune signaling of cytokines/chemokines and specific cytotoxic proteins releases. Advances in identification of multiple genetic alleles associated with specific drugs related SCARS in different populations is an important breakthrough in recent years for prevention of SCARs. This article summarized the findings on genetic factors related to SJS/TEN, especially for HLA.

摘要

严重皮肤不良反应(SCARs)包括史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)以及伴有嗜酸性粒细胞增多和全身症状的药物疹(DRESS),是由T细胞介导的危及生命的免疫反应,最常见由药物诱发。过去十年间,SCARs研究取得了重大进展。近期研究揭示了SCARs的发病机制,涉及易感基因,包括人类白细胞抗原(HLA)以及药物与T细胞受体(TCR)的相互作用,这种相互作用可能通过细胞因子/趋化因子的下游免疫信号传导和特定细胞毒性蛋白的释放来触发T细胞活化。在不同人群中鉴定与特定药物相关的SCARs相关的多个基因等位基因方面取得的进展是近年来预防SCARs的一项重要突破。本文总结了与SJS/TEN相关的遗传因素的研究结果,特别是关于HLA的研究结果。

相似文献

1
Genetics of Severe Cutaneous Adverse Reactions.
Front Med (Lausanne). 2021 Jul 15;8:652091. doi: 10.3389/fmed.2021.652091. eCollection 2021.
2
Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
J Dermatol Sci. 2012 Jun;66(3):190-6. doi: 10.1016/j.jdermsci.2012.04.002. Epub 2012 Apr 11.
3
4
Chemokines in Severe Cutaneous Adverse Reactions (SCARs).
Biomolecules. 2021 Jun 6;11(6):847. doi: 10.3390/biom11060847.
5
Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies.
Expert Rev Clin Immunol. 2020 Apr;16(4):373-387. doi: 10.1080/1744666X.2020.1740591. Epub 2020 Apr 2.
6
Pharmacogenomic Advances in the Prediction and Prevention of Cutaneous Idiosyncratic Drug Reactions.
Clin Pharmacol Ther. 2017 Jul;102(1):86-97. doi: 10.1002/cpt.683. Epub 2017 Jun 3.
7
Association between alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions.
Front Pharmacol. 2023 Sep 19;14:1248386. doi: 10.3389/fphar.2023.1248386. eCollection 2023.
9
Genotyping alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art.
Expert Opin Drug Metab Toxicol. 2021 Sep;17(9):1049-1064. doi: 10.1080/17425255.2021.1946514. Epub 2021 Jul 8.
10
Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
Curr Allergy Asthma Rep. 2018 Mar 24;18(4):26. doi: 10.1007/s11882-018-0778-6.

引用本文的文献

1
Pharmaco-Multiomics: A New Frontier in Precision Psychiatry.
Int J Mol Sci. 2025 Jan 26;26(3):1082. doi: 10.3390/ijms26031082.
2
Updates in SJS/TEN: collaboration, innovation, and community.
Front Med (Lausanne). 2023 Oct 11;10:1213889. doi: 10.3389/fmed.2023.1213889. eCollection 2023.
3
Molecular insights into the HLA-B35 molecules' classification associated with HIV control.
Immunol Cell Biol. 2024 Jan;102(1):34-45. doi: 10.1111/imcb.12698. Epub 2023 Oct 9.
4
Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions.
Int J Mol Sci. 2023 Aug 8;24(16):12577. doi: 10.3390/ijms241612577.
5
Associations of and with vancomycin-induced drug reaction with eosinophilia and systemic symptoms in the Han-Chinese population.
Front Pharmacol. 2022 Nov 25;13:954596. doi: 10.3389/fphar.2022.954596. eCollection 2022.
6
The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis.
Arthritis Rheumatol. 2022 Jul;74(7):1122-1131. doi: 10.1002/art.42137. Epub 2022 May 29.
7
Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists' Viewpoint.
Indian Dermatol Online J. 2022 Jan 24;13(1):10-12. doi: 10.4103/idoj.idoj_2_22. eCollection 2022 Jan-Feb.

本文引用的文献

1
Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions.
Pharmgenomics Pers Med. 2021 Jan 13;14:61-75. doi: 10.2147/PGPM.S290781. eCollection 2021.
2
Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia.
PLoS Negl Trop Dis. 2020 Oct 16;14(10):e0008746. doi: 10.1371/journal.pntd.0008746. eCollection 2020 Oct.
3
The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
J Dermatol Sci. 2020 Dec;100(3):175-182. doi: 10.1016/j.jdermsci.2020.09.009. Epub 2020 Sep 28.
4
Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians.
J Allergy Clin Immunol. 2021 Apr;147(4):1402-1412. doi: 10.1016/j.jaci.2020.08.003. Epub 2020 Aug 10.
5
Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions.
Front Pharmacol. 2020 Jul 2;11:969. doi: 10.3389/fphar.2020.00969. eCollection 2020.
6
The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses.
Expert Opin Drug Saf. 2020 Oct;19(10):1349-1356. doi: 10.1080/14740338.2020.1796965. Epub 2020 Aug 18.
8
Searching for the Culprit Drugs for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from a Nationwide Claim Database in Korea.
J Allergy Clin Immunol Pract. 2020 Feb;8(2):690-695.e2. doi: 10.1016/j.jaip.2019.09.032. Epub 2019 Oct 12.
9
Identification of drug-specific public TCR driving severe cutaneous adverse reactions.
Nat Commun. 2019 Aug 8;10(1):3569. doi: 10.1038/s41467-019-11396-2.
10
HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans.
Allergy. 2019 Nov;74(11):2227-2230. doi: 10.1111/all.13821. Epub 2019 May 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验